ASH 2024: Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care - Episode 1

Initial Treatment Strategies for Polycythemia Vera

, , , ,

Panelists discuss how they approach the evaluation and diagnosis of polycythemia vera (PV), including key clinical manifestations, and how they assess disease risk to determine initial treatment strategies based on NCCN guidelines, considering factors that differentiate low-risk from high-risk PV.

Now Viewing
EP. 1: Initial Treatment Strategies for Polycythemia Vera

Video content above is prompted by the following:

  1. Briefly provide an overview of PV and pathobiology.
  • What clinical manifestations best inform your evaluation and diagnosis of PV?

2. Please comment on disease risk and initial therapy for patients with PV.

  • What key factors do you consider when assessing low- versus high-risk PV?
  • What is your initial treatment strategy for patients with PV?